Novo Nordisk supports the GRI – as an Organisational Stakeholder – and its initiatives to drive sustainability reporting. Novo Nordisk reports – and has done so since 2002 – in accordance with the Global Reporting Initiative Sustainability Reporting Guidelines. To learn about our GRI reporting history see here.
The 2008 reporting cycle is using G3 Sustainability Reporting Guidelines. The Guidelines provide a disclosure framework of management approaches and performance against indicators for economic, environmental and social impacts, human rights, product responsibility and societal activities, as well as a company profile.
On the basis of a careful analysis of the GRI guidance and requirements, we are declaring an Application Level of A+ for the Novo Nordisk Annual Report 2008 (print and online).
For a description of the organisational profile, report profile, and the report scope and boundary according to the indicators, see here.
Novo Nordisk has a governance structure in place that oversees the company's sustainability-driven initiatives. Dedicated committees, chaired by a representative of the executive management are charged with the overall responsibility for areas such as people, environment, bioethics, occupational health & safety and global health. See management approach for specific areas here.
Measures of the impact or effect of the company divided into integrated economic, environmental and social performance indicators. See performance indicators for the specific areas here.